Showing 1,781 - 1,800 results of 4,491 for search 'significantly ((((((less decrease) OR (largest decrease))) OR (mean decrease))) OR (nn decrease))', query time: 0.56s Refine Results
  1. 1781
  2. 1782
  3. 1783
  4. 1784
  5. 1785
  6. 1786
  7. 1787
  8. 1788
  9. 1789
  10. 1790
  11. 1791
  12. 1792
  13. 1793
  14. 1794

    Study data. by Jie Liu (15128)

    Published 2025
    “…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”
  15. 1795

    Summary of clinical outcomes after 9 months. by Jie Liu (15128)

    Published 2025
    “…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”
  16. 1796

    Approval by the research ethics committee. by Jie Liu (15128)

    Published 2025
    “…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”
  17. 1797
  18. 1798
  19. 1799

    Risk Illustration. by Iftikhar Ali Ch (20783753)

    Published 2025
    “…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …”
  20. 1800

    Predictors of SCD. by Iftikhar Ali Ch (20783753)

    Published 2025
    “…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …”